T80.81 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Codes
- T80.810 Extravasation of vesicant antineoplastic chemotherapy
- T80.810A Extravasation of vesicant antineoplastic chemotherapy, initial encounter
- T80.810D Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter
- T80.810S Extravasation of vesicant antineoplastic chemotherapy, sequela
- T80.818 Extravasation of other vesicant agent
- T80.818A Extravasation of other vesicant agent, initial encounter
- T80.818D Extravasation of other vesicant agent, subsequent encounter
- T80.818S Extravasation of other vesicant agent, sequela
Possible back-references that may be applicable or related to T80.81 ICD10 Code:
- S00-T88 Injury, poisoning and certain other consequences of external causes
- T80-T88 Complications of surgical and medical care, not elsewhere classified
- T80 Complications following infusion, transfusion and therapeutic injection
- T80.0 Air embolism following infusion, transfusion and therapeutic injection
- T80.1 Vascular complications following infusion, transfusion and therapeutic injection
- T80.2 Infections following infusion, transfusion and therapeutic injection
- T80.3 ABO incompatibility reaction due to transfusion of blood or blood products
- T80.4 Rh incompatibility reaction due to transfusion of blood or blood products
- T80.A Non-ABO incompatibility reaction due to transfusion of blood or blood products
- T80.5 Anaphylactic reaction due to serum
- T80.6 Other serum reactions
- T80.8 Other complications following infusion, transfusion and therapeutic injection
- T80.9 Unspecified complication following infusion, transfusion and therapeutic injection
Present On Admission (POA Exempt)
T80.81 ICD 10 code is considered exempt from POA reporting